ARTIVION, INC.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
AORT$20.47-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Net cash flows from operating activities: | ||
| Net income (loss) | $1,417 | $(505) |
| Adjustments to reconcile net income (loss) to net cash from operating activities: | ||
| Depreciation and amortization | 6,340 | 5,446 |
| Non-cash compensation | 8,414 | 8,045 |
| Non-cash lease expense | 1,297 | 1,226 |
| Write-down of inventories and deferred preservation costs | 1,062 | 1,312 |
| Deferred income taxes | (524) | — |
| Change in fair value of contingent consideration | 1,740 | (2,830) |
| Other | 537 | (2,891) |
| Changes in operating assets and liabilities: | ||
| Receivables | (2,760) | (7,922) |
| Inventories and deferred preservation costs | (6,379) | (2,453) |
| Prepaid expenses and other assets | (1,286) | (327) |
| Accounts payable, accrued expenses, and other liabilities | (8,704) | (16,054) |
| Net cash flows provided by (used in) operating activities | 1,154 | (16,953) |
| Net cash flows from investing activities: | ||
| Capital expenditures | (8,003) | (3,638) |
| Payments related to sale of non-financial assets | (1,500) | — |
| Payments for Endospan agreements | (1,000) | — |
| Net cash flows used in investing activities | (10,503) | (3,638) |
| Net cash flows from financing activities: | ||
| Repayment of debt | — | (66) |
| Proceeds from exercise of stock options and issuance of common stock | 1,250 | 4,181 |
| Principal payments on short-term notes payable | (577) | — |
| Other | (210) | (178) |
| Net cash flows provided by financing activities | 463 | 3,937 |
| Effect of exchange rate changes on cash and cash equivalents | (258) | 884 |
| Decrease in cash and cash equivalents | (9,144) | (15,770) |
| Cash and cash equivalents beginning of period | 64,908 | 53,463 |
| Cash and cash equivalents end of period | $55,764 | $37,693 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.